The FDA said today it has begun more closely scrutinizing the roles of certain materials associated with harm to patients who have breast implants, nitinol-containing devices, metal-on-metal hip implants and devices made from animal-derived substances.
What I appreciate the most about genae is the consistent level of quality they produce. Our medical device study team is knowledgeable, capable and experienced; flexible with our changing needs, and very responsive to our concerns.
— Sara Vidmar, Vice President Clinical & Regulatory Affairs, Mitralign Inc., USA
Want to hear more about our services or how we can support your project? Feel free to contact us with any questions you may have.Contact us